Hypertension Registry: Study of Primary and Secondary Hypertension Phenotypes, Complications, and Treatment Personalization.
Launched by MOROCCAN SOCIETY OF CARDIOLOGY · Jan 9, 2025
Trial Information
Current as of June 13, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Hypertension Registry, aims to study high blood pressure, also known as hypertension, in Morocco. Researchers want to understand the different types of hypertension, its complications, and how to personalize treatment for patients. They will collect health information from patients aged 18 and older who have been diagnosed with hypertension. This data will include details like weight, height, blood pressure readings, and tests for blood sugar and cholesterol levels. The goal is to improve the quality of care that patients receive in primary healthcare settings by comparing current practices with guidelines from professional organizations.
To participate in the study, individuals need to be over 18 years old and have specific blood pressure readings that indicate hypertension. They must also agree to have their data included in the registry. Participants can expect to provide their health information through a secure system, and their privacy will be protected. This study is important because it will help identify gaps in current care for hypertension and suggest better ways to manage this common condition, ultimately aiming to improve health outcomes for patients in Morocco.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals aged over 18 years.
- * Patients with blood pressure:
- • Higher than 140 mmHg systolic and/or higher or equal to 90 mmHg diastolic in consultation or in a hospital setting.
- • Higher than 135/85 mmHg at home or in ambulatory blood pressure measurements (ABPM).
- • Patients who have agreed and signed the informed consent.
- • Patients with legal status in the Moroccan kingdom.
- Exclusion Criteria:
- • Patient without diagnosis of hypertension
- • Patient under 18 years old
- • Patients refusing to sign the informed consent.
- • Patients with illegal status in the kingdom.
About Moroccan Society Of Cardiology
The Moroccan Society of Cardiology is a prominent professional organization dedicated to advancing cardiovascular health in Morocco through research, education, and collaboration. Committed to improving patient outcomes, the society plays a pivotal role in the design and sponsorship of clinical trials that explore innovative treatments and interventions in cardiology. By fostering partnerships among healthcare professionals, researchers, and institutions, the Moroccan Society of Cardiology aims to enhance clinical practices and promote evidence-based approaches in the prevention and management of cardiovascular diseases within the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Casablanca, , Morocco
Casablanca, , Morocco
Meknès, , Morocco
Rabat, , Morocco
Rabat, , Morocco
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported